MAY 03, 2022 8:00 AM PDT

Unlocking the genomics of cancer using Sanger sequencing and fragment analysis

Sponsored by: Thermo Fisher Scientific
Speaker

Abstract

Cancer is a disease of the genome, and as such, tools that can analyze the genome are instrumental in understanding the mechanisms that lead to cancer, detecting cancerous cells, and providing avenues to research cancer treatments.   Sanger sequencing and fragment analysis using gold-standard capillary electrophoresis (CE) technology continues to play an instrumental role in unlocking cancer biology due its flexibility, simple workflow, and accuracy for focused sequence analysis.  We discuss the proven utility of these genomic tools in modeling disease, assessing microsatellite instability (MSI), detecting rare alleles, authenticating samples, and confirming CRISPR gene editing.  Additionally, we highlight recent advances in CE applications and instrumentation.

Key topics:

  • Accuracy and simple workflow of MSI and minor variant detection
  • Application of sample and cell line authentication in cancer modeling & therapeutic development
  • Flexibility and precision of CE for analyzing results of CRISPR genome editing experiments
  • Benefits of the latest generation CE-based genetic analyzer, SeqStudio™ Flex in accelerating cancer research

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
Loading Comments...
Show Resources